Spironolactone Tablet, Film Coated
Product Images NDC 55154-5517

4 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 55154-5517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Structural Formula (Image 01)

Spironolactone Structural Formula (Image 01)
Chemical structure of spironolactone depicted as a skeletal formula showing carbon rings, methyl groups, and functional groups consistent with its steroidal lactone structure.*
FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Image 02)

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Image 02)
A Kaplan-Meier survival probability curve comparing Spironolactone and placebo groups over 48 months. The y-axis represents probability from 0 to 1, and the x-axis shows time in months. Two curves display outcomes for Spironolactone (n=822) and placebo (n=841), with a noted log-rank p-value of less than 0.001.*
FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Image 03)

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Image 03)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing Spironolactone versus placebo. Subgroups include age, sex, race, LVEF, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use, with HR values plotted on a scale from 0.2 to 1.4 indicating relative benefit between Spironolactone and placebo.*
FDA Label Image

25mg Bag Label (3a873ff3 7c53 Afd9 E063 6294a90a155f 00)

25mg Bag Label (3a873ff3 7c53 Afd9 E063 6294a90a155f 00)
Spironolactone 25 mg film-coated tablets label showing 10 tablets per package. The label includes dosage strength, description of the tablet appearance, storage instructions, warnings, manufacturer and distributor information including Cardinal Health as distributor. The tablet is white, round, debossed with \"M\" over \"146\" on one side, and is packaged in an amber blister.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.